Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model. Hu Y, Turner MJ, Shields J, Gale MS, Hutto E, Roberts BL, Siders WM, Kaplan JM Immunology. 2009 Oct; 128(2):260-70. PMID: 19740383. Abstract CommentRecommendBookmarkWatch